Sign In
Sign Out
My Account
Subscribe
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
Special reports
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 23, 2020
View Archived Issues
Equine encephalitis' entry elucidated
Read More
Initiation of RHB-204 phase III trial as first-line treatment of nontuberculous mycobacteria disease
Read More
SPL-7013 demonstrates potent antiviral activity against human RSV
Read More
MD Anderson and Obsidian collaborate to advance novel cytoTIL therapy for solid tumors
Read More
EicOsis completes phase Ia single-ascending dose trial of EC-5026
Read More
Immunity stays strong in longest-term COVID study to date
Read More
Slowing cholera down protects survivors of infection
Read More
Abbisko Therapeutics patents ROR-gammaT agonists
Read More
Beijing Jialin Pharmaceutical discloses new SMARCA2-targeting compounds
Read More
AiCuris presents new HBV inhibitors
Read More
Genfleet Therapeutics synthesizes KRAS inhibitors
Read More
Initial phase I data presented for BMS-986253 plus nivolumab in advanced cancer
Read More
Early first-in-human data reported for AMG-404
Read More
GSK presents phase II data for linerixibat, a potential oral treatment for primary biliary cirrhosis
Read More
RAP-011: a sotatercept analogue active in in vivo models of PAH
Read More
First cohort dosed in Molecular Partners' phase I study of COVID-19 candidate MP-0420
Read More
Tebentafusp improves OS in phase III trial in metastatic uveal melanoma
Read More
Bio-Path studies BP-1002 in refractory or relapsed lymphoma and CLL
Read More
FDA issues EUA for Regeneron's casirivimab and imdevimab for mild to moderate COVID-19
Read More
Neglected tropical ecosystems: Coral reef denizen's microbiome yields candidate Candida fighters
Read More
Phase II dosing begins with brequinar to treat COVID-19
Read More
Pooled analysis shows AZD-1222 effective at preventing COVID-19
Read More
European Commission approves quadrivalent meningococcal conjugate vaccine MenQuadfi
Read More
BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe